Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-16

Clinical Trial Update: Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's [NA]

View source ↗

Summary

A terminated clinical trial investigating low-dose radiotherapy to reduce cerebral amyloidosis in early Alzheimer's disease; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Alzheimer's Disease | NA | Status: TERMINATED | Results posted: 2021-12-16